PCM - Pharma Consulting & Management GmbH > In-/Out-Licensing > Ethical > Octreotide acetate - available for licensing

Ethical pharmaceuticals

Octreotide acetate

Octreotide acetate is a synthetic Somatostatin-analogue.


Treatment of acromegaly,

Symptomatic treatment of endocrine tumors of the gastrointestinal tract,

Prophylaxis for postoperative pancreatic complications following pancreatic surgery.

Pharmaceutical form and presentations

Solution for injection.

0,05 mg/ml in 1 ml ampoule,

0,1 mg/ml in 1 ml ampoule,

0,5 mg/ml in 1 ml ampule,

0,2 mg/ml in 5 ml injection vial.

Please note that this is not the slow release form, known as Octreotide LAR.


Subcutaneous injection.

Produced in

European Union.

Available countries

On request.


Regulatory status, indications and product information may vary from country to country.

Product descriptions provide basic information and are not usage instructions.

Please observe the officially approved product information.